Osteoarthritis Clinical Study Information - Pico-Tesla Magnetic Therapies, LLC

		Osteoarthritis Clinical Study Information The Resonator™ device uses electro-magnetic stimulation in order to relieve symptoms of a disorder or disease. Overview Device User Interface Safety and Risks FDA Clearance Overview The Resonator™ Device Compared to Other Magnetic Devices and Parkinson’s Disease Therapies The Device Versus MRI (Magnetic Resonance Imaging) The Device Versus TMS and rTMS The Device Versus Other Parkinson’s Disease Therapies Overview Jacobson Resonance™

Please Download the latest version of Adobe Flash Player.

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

Study Information
Contact Information
Test Sites
Purpose & Overview
Worldwide Regulatory Status

Device Information
Device Information
Device Details
Signal Generation
Helmholtz Coils
Determination of Device Safety
Institutional Review Board (IRB)

Study Details
Study Indication
Etiology
Symptoms
Diagnosis
Treatments
Study Treatment Modality: EM Stimulation
Theory of Mechanism of Operation (Part 1)
Theory of Mechanism of Operation (Part 2)
Theory of Mechanism of Operation (Part 3)
EM Stimulation Therapy Rationale
rTMS / TMS
Research (Part 1)
Research (Part 2)
Supporting Materials (Part 1)
Supporting Materials (Part 2)
Supporting Materials (Part 3)
Supporting Materials (Part 4)

Study Design
Procedure Groups
Double-Blind Design
Subjects
Study Test Battery (Part 1)
Study Test Battery (Part 2)
Study Test Battery (Part 3)
Study Test Battery (Part 4)
Pre-Procedure Activities
Inclusion Criteria
Exclusion Criteria
Baseline Assessment

Study Procedures
Standardization Phase
Study Procedure Administration Protocol
During-Procedure Activities
Pre- and Post-Procedure Administration Phases
Post-Procedure Activities
Post-Procedure Activities (Days 15-42)
Statistical Analysis Plan
Secondary Efficacy Outcome
Statistical Methods & Analysis
Safety Analysis
Early Termination Visit
Safety and Confidentiality Issues

STUDY TEST BATTERY

The following is a listing of all of the evaluation tools that will be used in this study, for test and placebo subjects alike.

The American College of Rheumatology (ACR) Classification Criteria for Osteoarthritis of the Hip Reference: R. Altman, G. Alarcon, D. Appelrouth, D. Bloch, D. Borenstein, K. Brandt, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505--514.

The American College of Rheumatology (ACR) has developed classification criteria for classification and reporting of osteoarthritis involving the hip that is the most widely recognized and used criteria for the classification and reporting of osteoarthritis of the hip.

This classification method yields a sensitivity of 86% and a specificity of 75%.

The ACR classification criteria for osteoarthritis of the hip is as follows:

Hip pain

Erythrocyte sedimentation rate (ESR) less than 20 mm/hour;
Radiographic femoral or acetabular osteophytes;
Radiographic joint space narrowing (superior, axial, and/or medial).

Because the presence of osteophytes on x-ray is a protocol required inclusion criteria (defined by a Kellgren-Lawrence x-ray Grade of >=2), the protocol defined requirement for diagnosis of osteoarthritis of the hip will be the presence of hip pain (1), presence of osteophytes on x-ray (3) and either an ESR < 20 mm/hour (2) OR joint space narrowing on x-ray (4).

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

Website design by DDA Medical

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical^®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.